{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:38:30Z","timestamp":1773092310099,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1002\/jps.23711","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T23:26:43Z","timestamp":1377214003000},"page":"4015-4023","source":"Crossref","is-referenced-by-count":20,"title":["Formulation Design and Optimization for the Improvement of Nystatin-Loaded Lipid Intravenous Emulsion"],"prefix":"10.1016","volume":"102","author":[{"given":"Deiry","family":"Mar\u00edn-Quintero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Fernandez-Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Calpena-Campmany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Montes-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Clares-Naveros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Del Pozo-Carrascosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23711_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eimc.2011.09.004","article-title":"General epidemiology of invasive fungal disease","volume":"30","author":"Pem\u00e1n","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1002\/jps.23711_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"10.1002\/jps.23711_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.det.2007.01.002","article-title":"Advances in topical and systemic antifungals","volume":"25","author":"Zhang","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1002\/jps.23711_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/589298","article-title":"Molecular epidemiology of candidemia: Evidence of clusters of smoldering nosocomial infections","volume":"47","author":"Asmundsd\u00f3ttir","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1002\/jps.23711_bb0025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/17425247.2010.525230","article-title":"Topical delivery of antifungal agents","volume":"7","author":"Kaur","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.23711_bb0030","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1016\/S0006-3495(03)70032-0","article-title":"Cooperative partition model of nystatin interaction with phospholipid vesicles","volume":"84","author":"Coutinho","year":"2003","journal-title":"Biophys J"},{"key":"10.1002\/jps.23711_bb0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0714.1999.tb02007.x","article-title":"The in vitro post-antifungal effect of nystatin on Candida species of oral origin","volume":"28","author":"Ellepola","year":"1999","journal-title":"J Oral Pathol Med"},{"key":"10.1002\/jps.23711_bb0040","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.44.10.2887-2890.2000","article-title":"In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect","volume":"44","author":"Gunderson","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23711_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2003.11.003","article-title":"The effects of Pluronic block copolymers on the aggregation state of nystatin","volume":"95","author":"Croy","year":"2004","journal-title":"J Control Release"},{"key":"10.1002\/jps.23711_bb0050","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1208\/pt030322","article-title":"Double-layered mucoadhesive tablets containing nystatin","volume":"3","author":"Llabot","year":"2002","journal-title":"AAPS PharmSciTech"},{"key":"10.1002\/jps.23711_bb0055","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s12272-010-1109-1","article-title":"Enhancement of dissolution of nystatin from buccoadhesive tablets containing various surfactants and a solid dispersion formulation","volume":"33","author":"Sakeer","year":"2010","journal-title":"Arch Pharm Res"},{"key":"10.1002\/jps.23711_bb0060","first-page":"67","article-title":"Development of liposomal polyene antibiotics: An historical perspective","volume":"6","author":"Ng","year":"2003","journal-title":"J Pharm Pharm Sci"},{"key":"10.1002\/jps.23711_bb0065","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1002\/jps.23249","article-title":"Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: Ultrastructural effects and release studies","volume":"101","author":"Fern\u00e1ndez Campos","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23711_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1439-0507.2012.02202.x","article-title":"Evaluation of novel nystatin nanoemulsion for skin candidosis infections","volume":"56","author":"Fernandez-Campos","year":"2012","journal-title":"Mycoses"},{"key":"10.1002\/jps.23711_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11046-009-9271-z","article-title":"Nystatin-intralipid preparation: Characterization and in vitro activity against yeasts and molds","volume":"169","author":"Semis","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1002\/jps.23711_bb0080","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3109\/03639045.2011.587431","article-title":"Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin","volume":"37","author":"El-Ridy","year":"2011","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.23711_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.carbpol.2013.01.005","article-title":"Novel microparticulate systems for the vaginal delivery of nystatin: Development and characterization","volume":"94","author":"Mart\u00edn-Villena","year":"2013","journal-title":"Carbohydr Polym"},{"key":"10.1002\/jps.23711_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejps.2013.03.006","article-title":"Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system","volume":"49","author":"P\u00e1l","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23711_bb0095","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1128\/JCM.40.4.1406-1412.2002","article-title":"In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical candida isolates","volume":"40","author":"Arikan","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1002\/jps.23711_bb0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2009.09.025","article-title":"Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion","volume":"383","author":"Shi","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23711_bb0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-5173(00)00692-X","article-title":"Physical properties and stability of two emulsion formulations of propofol","volume":"215","author":"Han","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23711_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00664-5","article-title":"Use of ultrasound to prepare lipid emulsions of Lorazepam for intravenous injection","volume":"216","author":"Medina","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23711_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23711_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of Akaike\u2019s information criterion (AIC) in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.23711_bb0125","series-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-P","year":"1998"},{"key":"10.1002\/jps.23711_bb0130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1\u03bc method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","author":"Rodr\u00edguez-Tudela","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/jps.23711_bb0135","series-title":"Manual of clinical microbiology","author":"Murray","year":"2003"},{"key":"10.1002\/jps.23711_bb0140","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s11095-006-9092-4","article-title":"Lipid injectable emulsions: Pharmacopeial and safety issues","volume":"23","author":"Driscoll","year":"2006","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23711_bb0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0261-5614(92)90031-K","article-title":"Fat emulsions for parenteral nutrition. I: Evaluation of microscopic and laser light scattering methods for the determination of the physical stability","volume":"11","author":"M\u00fcller","year":"1992","journal-title":"Clin Nutr"},{"key":"10.1002\/jps.23711_bb0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.colsurfb.2012.10.061","article-title":"Transdermal delivery of imipramine and doxepin from newly oil-in-water nanoemulsions for an analgesic and anti-allodynic activity: Development, characterization and in vivo evaluation","volume":"103","author":"Gimeno-Sandig","year":"2013","journal-title":"Colloid Surf B Biointerfaces"},{"key":"10.1002\/jps.23711_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.colsurfb.2009.03.007","article-title":"Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent","volume":"72","author":"Celia","year":"2009","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1002\/jps.23711_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","article-title":"On the use of the Weibull function for the discernment of drug release mechanisms","volume":"17","author":"Papadopoulou","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23711_bb0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2010.12.020","article-title":"Modeling of drug release from bulk-degrading polymers","volume":"418","author":"Lao","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23711_bb0170","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/03639040903261997","article-title":"Drug release from lipid liquid crystalline phases: Relation with phase behaviour","volume":"36","author":"Costa-Balogh","year":"2010","journal-title":"Drug Dev Ind Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915308443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915308443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T19:56:49Z","timestamp":1539460609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915308443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0022354915308443"],"URL":"https:\/\/doi.org\/10.1002\/jps.23711","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}